Pre-emptive asthma risk notifications based on medicament device monitoring

US11769598B2 · kind B2 · utility

Assignee

• Reciprocal Labs Corporation · US

Inventors

• Meredith A. Barrett · Redwood City, US
• Mike Lohmeier · Sun Prairie, US
• Shannon M. Hamilton · Berkeley, US
• Michael J. Tuffli · Kentfield, US
• Dmitry Stupakov · Cupertino, US
• Christopher Hogg · San Francisco, US
• John David Van Sickle · Oregon, US
• Gregory F. Tracy · Madison, US
• Mark Sehmer · Stoughton, US
• Robert Austin Lee · San Francisco, US

Key dates

• Filing date: May 20, 2019
• Grant date: Sep 26, 2023
• Expiry date: May 20, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2209/06
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

This description provides risk notifications for a geographic region to inform patients and effect behavior changes to prevent rescue events and exacerbations from occurring. A risk analysis for a geographic region is based on data gathered from a population of patients who may experience respiratory events within the geographic region. Rescue medication events, environmental conditions relevant to the rescue medication events, and other contextually relevant information are detected by sensors associated with a population of patients' medicament device/s and are collected from other sources, respectively, to provide a basis to determine a risk score. This data is analyzed to determine the severity of the risk of a respiratory event occurring within a geographical region and accordingly sending a notification to patients within that geographical region.